132 related articles for article (PubMed ID: 34147517)
1. Injection-Molded Coamorphous Tablets: Analysis of Intermolecular Interaction and Crystallization Propensity.
Tanaka R; Ishihara S; Sasaki T; Hattori Y; Otsuka M
J Pharm Sci; 2021 Sep; 110(9):3289-3297. PubMed ID: 34147517
[TBL] [Abstract][Full Text] [Related]
2. Coamorphous Loratadine-Citric Acid System with Enhanced Physical Stability and Bioavailability.
Wang J; Chang R; Zhao Y; Zhang J; Zhang T; Fu Q; Chang C; Zeng A
AAPS PharmSciTech; 2017 Oct; 18(7):2541-2550. PubMed ID: 28224393
[TBL] [Abstract][Full Text] [Related]
3. Drug-Excipient Interactions: Effect on Molecular Mobility and Physical Stability of Ketoconazole-Organic Acid Coamorphous Systems.
Fung MH; DeVault M; Kuwata KT; Suryanarayanan R
Mol Pharm; 2018 Mar; 15(3):1052-1061. PubMed ID: 29309158
[TBL] [Abstract][Full Text] [Related]
4. Enhanced Physical Stability and Synchronized Release of Febuxostat and Indomethacin in Coamorphous Solids.
Moinuddin SM; Shi Q; Tao J; Guo M; Zhang J; Xue Q; Ruan S; Cai T
AAPS PharmSciTech; 2020 Jan; 21(2):41. PubMed ID: 31898765
[TBL] [Abstract][Full Text] [Related]
5. Incorporation of Complexation into a Coamorphous System Dramatically Enhances Dissolution and Eliminates Gelation of Amorphous Lurasidone Hydrochloride.
Heng W; Su M; Cheng H; Shen P; Liang S; Zhang L; Wei Y; Gao Y; Zhang J; Qian S
Mol Pharm; 2020 Jan; 17(1):84-97. PubMed ID: 31794225
[TBL] [Abstract][Full Text] [Related]
6. Mechanistic insights into the crystallization of coamorphous drug systems.
Heng W; Song Y; Luo M; Hu E; Wei Y; Gao Y; Pang Z; Zhang J; Qian S
J Control Release; 2023 Feb; 354():489-502. PubMed ID: 36646287
[TBL] [Abstract][Full Text] [Related]
7. Physical Stability and Dissolution Behavior of Ketoconazole-Organic Acid Coamorphous Systems.
Fung M; Be Rziņš KR; Suryanarayanan R
Mol Pharm; 2018 May; 15(5):1862-1869. PubMed ID: 29528656
[TBL] [Abstract][Full Text] [Related]
8. Coamorphous repaglinide-saccharin with enhanced dissolution.
Gao Y; Liao J; Qi X; Zhang J
Int J Pharm; 2013 Jun; 450(1-2):290-5. PubMed ID: 23612357
[TBL] [Abstract][Full Text] [Related]
9. Sinomenine-phenolic acid coamorphous drug systems: Solubilization, sustained release, and improved physical stability.
Chen X; Li D; Zhang H; Duan Y; Huang Y
Int J Pharm; 2021 Apr; 598():120389. PubMed ID: 33609724
[TBL] [Abstract][Full Text] [Related]
10. Physical stability and solubility of the thermotropic mesophase of fenoprofen calcium as pure drug and in a tablet formulation.
Patterson J; Bary A; Rades T
Int J Pharm; 2002 Oct; 247(1-2):147-57. PubMed ID: 12429493
[TBL] [Abstract][Full Text] [Related]
11. Coamorphization combined with complexation enhances dissolution of lurasidone hydrochloride and puerarin with synchronized release.
Wang S; Heng W; Wang X; He X; Zhang Z; Wei Y; Zhang J; Gao Y; Qian S
Int J Pharm; 2020 Oct; 588():119793. PubMed ID: 32827676
[TBL] [Abstract][Full Text] [Related]
12. Coamorphous drug systems: enhanced physical stability and dissolution rate of indomethacin and naproxen.
Löbmann K; Laitinen R; Grohganz H; Gordon KC; Strachan C; Rades T
Mol Pharm; 2011 Oct; 8(5):1919-28. PubMed ID: 21815614
[TBL] [Abstract][Full Text] [Related]
13. Crystallization kinetics and molecular dynamics of binary coamorphous systems of nimesulide and profen analogs.
Zhang J; Shi Q; Qu T; Zhou D; Cai T
Int J Pharm; 2021 Dec; 610():121235. PubMed ID: 34743960
[TBL] [Abstract][Full Text] [Related]
14. Integrated hot-melt extrusion - injection molding continuous tablet manufacturing platform: Effects of critical process parameters and formulation attributes on product robustness and dimensional stability.
Desai PM; Hogan RC; Brancazio D; Puri V; Jensen KD; Chun JH; Myerson AS; Trout BL
Int J Pharm; 2017 Oct; 531(1):332-342. PubMed ID: 28844899
[TBL] [Abstract][Full Text] [Related]
15. Preparation and Characterization of a Rifampicin Coamorphous Material with Tromethamine Coformer: An Experimental-Theoretical Study.
Queiroz LHS; Barros RS; de Sousa FF; Lage MR; Sarraguça MC; Ribeiro PRS
Mol Pharm; 2024 Mar; 21(3):1272-1284. PubMed ID: 38361428
[TBL] [Abstract][Full Text] [Related]
16. Characterization of Solid Dispersion of Itraconazole Prepared by Solubilization in Concentrated Aqueous Solutions of Weak Organic Acids and Drying.
Parikh T; Sandhu HK; Talele TT; Serajuddin AT
Pharm Res; 2016 Jun; 33(6):1456-71. PubMed ID: 26951566
[TBL] [Abstract][Full Text] [Related]
17. Effect of Organic Acids on Molecular Mobility, Physical Stability, and Dissolution of Ternary Ketoconazole Spray-Dried Dispersions.
Fung MH; Suryanarayanan R
Mol Pharm; 2019 Jan; 16(1):41-48. PubMed ID: 30359037
[TBL] [Abstract][Full Text] [Related]
18. Triple Strategies to Improve Oral Bioavailability by Fabricating Coamorphous Forms of Ursolic Acid with Piperine: Enhancing Water-Solubility, Permeability, and Inhibiting Cytochrome P450 Isozymes.
Yu D; Kan Z; Shan F; Zang J; Zhou J
Mol Pharm; 2020 Dec; 17(12):4443-4462. PubMed ID: 32926628
[TBL] [Abstract][Full Text] [Related]
19. Advances in coamorphous drug delivery systems.
Shi Q; Moinuddin SM; Cai T
Acta Pharm Sin B; 2019 Jan; 9(1):19-35. PubMed ID: 30766775
[TBL] [Abstract][Full Text] [Related]
20. Design of a Stable Coamorphous System Using Lactose as an Antiplasticizing Agent for Diphenhydramine Hydrochloride with a Low Glass Transition Temperature.
Ueda H; Hirakawa Y; Miyano T; Imono M; Tse JY; Uchiyama H; Tozuka Y; Kadota K
Mol Pharm; 2022 Apr; 19(4):1209-1218. PubMed ID: 35316068
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
